Annual Drug Patent Expirations for AIRDUO+RESPICLICK
Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from three suppliers. There are twenty-one patents protecting this drug.
Drug patent litigation for AIRDUO RESPICLICK.
This drug has three hundred and sixty patent family members in thirty-six countries.
The generic ingredient in AIRDUO RESPICLICK is fluticasone propionate; salmeterol xinafoate. Three suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
